BioLineRx's BL-8040 Receives Orphan Drug Designation for Treatment of AML

News   Sep 10, 2013

 
BioLineRx's BL-8040 Receives Orphan Drug Designation for Treatment of AML
 
 
 

RELATED ARTICLES

Arrow Poison Potential Male Birth Control

News

Women have many options for oral contraceptives that are safe, effective and reversible, but despite decades of research, men have none. Now, scientists report a rat study that shows they finally have a good lead for a male birth control pill. It's based on ouabain, a plant extract that African warriors and hunters traditionally used as a heart-stopping poison on their arrows.

READ MORE

PPD and Quotient Sciences Form Innovative Partnership to Accelerate Pediatric Drug Development

News

Will shorten timelines, reduce costs and simplify contracting process in pediatric programs.

READ MORE

Metrohm USA Opens Its New Headquarters in Florida

News

Metrohm USA welcomes its Tampa employees to their new North American headquarters in Riverview, Florida.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE